Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis

Open access
Kusumi, Ichiro, Boku, Shuken, Takahashi, Yoshito · 2015 · Psychiatry and Clinical Neurosciences

Abstract

The original definition of atypical antipsychotic drugs (APD) was drugs that are effective against positive symptoms in schizophrenia with no or little extrapyramidal symptoms (EPS). However, atypical APD have been reported to be more effective for cognitive dysfunction and negative symptoms in schizophrenia than typical APD, which expands the definition of ‘atypicality’. This article provides a critical review of the pharmacology of atypical APD, especially from the viewpoint of receptor binding profiles and neurotransmitter regulations as well as neuroprotection and neurogenesis. A variety of serotonin (5‐HT) receptors, such as 5‐HT 2A/2C, 5‐HT 1A, 5‐HT 6and 5‐HT 7receptors, may contribute to the mechanisms of action of ‘atypicality’. The dopaminergic modulations, including a low affinity for dopamine D 2receptors and a partial D 2receptor agonistic action, and glutamatergic regulations may also be involved in the pharmacological backgrounds of ‘atypicality’. Atypical APD, but not typical APD, may facilitate cortical neuroprotection and hippocampal neurogenesis, which might be a part of the action mechanisms of atypical APD. The facilitation of cortical neuroprotection and hippocampal neurogenesis induced by atypical APD might be mediated by an increase in the Ser9 phosphorylation of glycogen synthase kinase‐3β (GSK‐3β). The stimulation of 5‐HT 1Areceptors and/or the blockade of 5‐HT 2receptors, which is characteristic of atypical APD, might increase Ser9 phosphorylation of GSK‐3β. Moreover, atypical APD increase brain‐derived neurotrophic factor (BDNF) levels.BDNF increases Ser9 phosphorylation of GSK‐3β and has neuroprotective and neurogenic effects, as in the case of atypical APD. These findings suggest that GSK‐3β might play a role in the action mechanisms of atypical APD, in both the 5‐HT‐dependent and BDNF‐dependent mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pcn.12242

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 166

Metadata

Authors
Kusumi, I., Boku, S., & Takahashi, Y.
Venue
Psychiatry and Clinical Neurosciences
Publisher
Wiley
Published
2014-11-06
Volume
69
Issue
5
Pages
243-258
ISSN
  • 1323-1316 (ISSN-L)
  • 1440-1819
OpenAlex
W2114678425
Cited by
166
References
15
FWCI
7.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.